Cargando…

A Real World Report on Intravenous High-Dose and Non-High-Dose Proton-Pump Inhibitors Therapy in Patients with Endoscopically Treated High-Risk Peptic Ulcer Bleeding

Background and Study Aims. The optimal dose of intravenous proton-pump inhibitor (PPI) therapy for the prevention of peptic ulcer (PU) rebleeding remains controversial. This study aimed to understand the real world experiences in prescribing high-dose PPI and non-high-dose PPI for preventing rebleed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Lung-Sheng, Lin, Sheng-Chieh, Kuo, Chung-Mou, Tai, Wei-Chen, Tseng, Po-Lin, Chang, Kuo-Chin, Kuo, Chung-Huang, Chuah, Seng-Kee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3403596/ https://www.ncbi.nlm.nih.gov/pubmed/22844276 http://dx.doi.org/10.1155/2012/858612

Ejemplares similares

Intravenous non-high-dose pantoprazole is equally effective as high-dose pantoprazole in preventing rebleeding among low risk patients with a bleeding peptic ulcer after initial endoscopic hemostasis
por: Liang, Chih-Ming, et al.
Publicado: (2012)

High or Nonhigh Doses of Proton Pump Inhibitors for Patients with Peptic Ulcer Bleeding?
por: Hsieh, Yu-Hsi, et al.
Publicado: (2013)

Predicting risk factors for rebleeding, infections, mortality following peptic ulcer bleeding in patients with cirrhosis and the impact of antibiotics prophylaxis at different clinical stages of the disease
por: Kuo, Ming-Te, et al.
Publicado: (2015)

High Dose versus Low Dose Intravenous Pantoprazole in Bleeding Peptic Ulcer: A Randomized Clinical Trial
por: Masjedizadeh, Abdol Rahim, et al.
Publicado: (2014)

Outcome of Holiday and Nonholiday Admission Patients with Acute Peptic Ulcer Bleeding: A Real-World Report from Southern Taiwan
por: Wu, Tsung-Chin, et al.
Publicado: (2014)

Effect of High-Dose Oral Rabeprazole on Recurrent Bleeding after Endoscopic Treatment of Bleeding Peptic Ulcers
por: Kim, Hyung-Keun, et al.
Publicado: (2012)

Oral versus intravenous proton pump inhibitors in preventing re-bleeding for patients with peptic ulcer bleeding after successful endoscopic therapy
por: Yen, Hsu-Heng, et al.
Publicado: (2012)

Risk of Rebleeding and Mortality in Cirrhotic Patients with Peptic Ulcer Bleeding: A 12-Year Nationwide Cohort Study
por: Yang, Shih-Cheng, et al.
Publicado: (2017)

The Influential Roles of Antibiotics Prophylaxis in Cirrhotic Patients with Peptic Ulcer Bleeding after Initial Endoscopic Treatments
por: Yang, Shih-Cheng, et al.
Publicado: (2014)

Comparison of Oral and Intravenous Proton Pump Inhibitor on Patients with High Risk Bleeding Peptic Ulcers: A Prospective, Randomized, Controlled Clinical Trial
por: Mostaghni, A A, et al.
Publicado: (2011)

High-Dose Proton Pump Inhibitors Are Superior to Standard-Dose Proton Pump Inhibitors in High-Risk Patients With Bleeding Ulcers and High-Risk Stigmata After Endoscopic Hemostasis
por: Zhu, Zhenhua, et al.
Publicado: (2021)

Peptic Ulcer Diseases: Genetics, Mechanism, and Therapies
por: Chuah, Seng-Kee, et al.
Publicado: (2014)

Intravenous versus oral omeprazole on patients with high risk bleeding peptic ulcers: A prospective randomized clinical trial protocol
por: Zhang, Jing, et al.
Publicado: (2021)

In-hospital and post-discharge outcomes of pediatric acute myocarditis underwent after high-dose steroid or intravenous immunoglobulin therapy
por: Lin, Ming-Shyan, et al.
Publicado: (2019)

Comparison of high and low-dose epinephrine & endoclip application in peptic ulcer bleeding: A case series analysis observational study
por: Akay, Tamer, et al.
Publicado: (2021)

Risk factors influencing the outcome of peptic ulcer bleeding in chronic kidney disease after initial endoscopic hemostasis: A nationwide cohort study
por: Liang, Chih-Ming, et al.
Publicado: (2016)

Oral Proton Pump Inhibitors May Be as Effective as Intravenous in Peptic Ulcer Bleeding: A Systematic Review and Meta-analysis
por: Csiki, Endre, et al.
Publicado: (2021)

The efficacy of limited endoscopic sphincterotomy plus endoscopic papillary large balloon dilation for removal of large bile duct stones
por: Kuo, Chung-Mou, et al.
Publicado: (2019)

Limited precut sphincterotomy combined with endoscopic papillary balloon dilation for common bile duct stone removal in patients with difficult biliary cannulation
por: Kuo, Chung-Mou, et al.
Publicado: (2016)

Risk factors determining the need for second-look endoscopy for peptic ulcer bleeding after endoscopic hemostasis and proton pump inhibitor infusion
por: Cheng, Hsiu-Chi, et al.
Publicado: (2016)

Effectiveness of intravenous immunoglobulin alone and intravenous immunoglobulin combined with high-dose aspirin in the acute stage of Kawasaki disease: study protocol for a randomized controlled trial
por: Kuo, Ho-Chang, et al.
Publicado: (2018)

The Association of Helicobacter pylori Eradication with the Occurrences of Chronic Kidney Diseases in Patients with Peptic Ulcer Diseases
por: Wang, Jiunn-Wei, et al.
Publicado: (2016)

Risk of Recurrent Peptic Ulcer Disease in Patients Receiving Cumulative Defined Daily Dose of Nonsteroidal Anti-Inflammatory Drugs
por: Liang, Chih-Ming, et al.
Publicado: (2019)

Comparison of Oral versus Intravenous Proton Pump Inhibitors in Preventing Re-bleeding from Peptic Ulcer after Successful Endoscopic Therapy
por: Valizadeh Toosi, Seyed Mohammad, et al.
Publicado: (2018)

Comparison of Oral versus Intravenous Proton Pump Inhibitors in Preventing Re-bleeding from Peptic Ulcer after Successful Endoscopic Therapy
por: Karim, Rashid, et al.
Publicado: (2020)

Factors Associated with Rebleeding in Patients with Peptic Ulcer Bleeding: Analysis of the Korean Peptic Ulcer Bleeding (K-PUB) Study
por: Kim, Joon Sung, et al.
Publicado: (2018)

A comparison between non-sedation and general endotracheal anesthesia for retrograde endoscopic common bile duct stone removal: A tertiary center experience
por: Liang, Chih-Ming, et al.
Publicado: (2019)

Retraction: Comparison of Oral versus Intravenous Proton Pump Inhibitors in Preventing Re-bleeding from Peptic Ulcer after Successful Endoscopic Therapy
por: Karim, Rashid, et al.
Publicado: (2021)

Effects of high-dose versus low-dose proton pump inhibitors for treatment of gastrointestinal ulcer bleeding: a meta-analysis of randomized controlled trials
por: Zhu, Wei, et al.
Publicado: (2022)

The fermented product of high-yield surfactin strain Bacillus subtilis LYS1 improves the growth performance and intestinal villi morphology in broilers
por: Lee, Yueh-Sheng, et al.
Publicado: (2023)

Endoscopic Obliteration for Bleeding Peptic Ulcer
por: Włodarczyk, A. W., et al.
Publicado: (1997)

Recent advances in peptic ulcer bleeding
por: Beales, Ian LP
Publicado: (2009)

Endoscopic Management of Peptic Ulcer Bleeding
por: Kim, Joon Sung, et al.
Publicado: (2015)

The treatment of bleeding peptic ulcer in the elderly
por: Fezzi, Margherita, et al.
Publicado: (2009)

Systematic review with network meta-analysis: dual therapy for high-risk bleeding peptic ulcers
por: Shi, Keda, et al.
Publicado: (2017)

Increased Risk of Osteoporosis in Patients With Peptic Ulcer Disease: A Nationwide Population-Based Study
por: Wu, Chieh-Hsin, et al.
Publicado: (2016)

An extended 36-week oral esomeprazole improved long-term recurrent peptic ulcer bleeding in patients at high risk of rebleeding
por: Chiang, Hsueh-Chien, et al.
Publicado: (2022)

Forrest Classification for Bleeding Peptic Ulcer: A New Look at the Old Endoscopic Classification
por: Yen, Hsu-Heng, et al.
Publicado: (2022)

Overcoming stability challenges during continuous intravenous administration of high-dose amoxicillin using portable elastomeric pumps
por: Binson, Guillaume, et al.
Publicado: (2019)

The Clinical and Bacteriological Factors for Optimal Levofloxacin-Containing Triple Therapy in Second-Line Helicobacter pylori Eradication
por: Tai, Wei-Chen, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ii6k6hujda8jihhtm40htlt6o3